Cationic liposomes exhibit a propensity to selectively target tumor-associated blood vessels demonstrating potential value as anti-cancer drug delivery vehicles. Their utility however, is hampered by their biological instability and rapid elimination following i.v. administration. Efforts to circumv
Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes
β Scribed by Amr S. Abu Lila; Tatsuhiro Ishida; Hiroshi Kiwada
- Book ID
- 106493938
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 396 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0724-8741
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Cationic liposomes (CLs) can accumulate in tumor vascular endothelial cells (VECs) to show high selective targeting ability. Therefore, chemotherapeutic agentβloaded CLs are considered as new therapeutic vehicles to enhance the treatment efficacy. This study investigated the effect of _
## Abstract Paclitaxel encapsulated in cationic liposomes (EndoTAGβ1) significantly impairs tumor growth by a significant reduction of functional tumor microcirculation and induction of endothelial cell apoptosis. The aim of the study was to analyze whether platelet activation within the tumor micr
Fibroblast growth factor receptors, overexpressed on the surface of a variety of tumor cells and on tumor neovasculature, are potential targets for tumor- and vascular-targeting therapy. The purpose of our present study was to compare the pharmacokinetics and tissue distribution of a novel truncated